Habtamu Biazin is an assistant professor of Microbiology in the Department of Microbiology and Immunology at Addis Ababa University, Ethiopia where I have contributed to academia since 2012. I hold a Bachelor of Medical Laboratory Science from AAU in 2012, and an MSc in 2017. I am currently a PhD candidate in Medical Microbiology at the same University. My research focuses on infectious diseases, immunology, biomarkers, antimicrobial resistance, cancer, and cutting-edge technologies in the diagnosis and prevention of infectious diseases and cancer.
Throughout my academic career, I have contributed to numerous publications, with 26 research papers and 184 citations to his name. My expertise spans various areas, including infection, epidemiology, tropical diseases, emerging infectious diseases, HIV, infectious disease transmission, and prevention.
In addition to my teaching and research roles, I am actively seeking collaboration on projects related to the molecular characterization of HPV, other STIs, and microbiome studies, particularly vaginal microbiota.
Habtamu Biazin is an assistant professor of Microbiology in the Department of Microbiology and Immunology at Addis Ababa University, Ethiopia where I have contributed to academia since 2012. I hold a Bachelor of Medical Laboratory Science from AAU in 2012, and an MSc in 2017. I am currently a PhD candidate in Medical Microbiology at the same University. My research focuses on infectious diseases, immunology, biomarkers, antimicrobial resistance, cancer, and cutting-edge technologies in the diagnosis and prevention of infectious diseases and cancer.
Throughout my academic career, I have contributed to numerous publications, with 26 research papers and 184 citations to his name. My expertise spans various areas, including infection, epidemiology, tropical diseases, emerging infectious diseases, HIV, infectious disease transmission, and prevention.
In addition to my teaching and research roles, I am actively seeking collaboration on projects related to the molecular characterization of HPV, other STIs, and microbiome studies, particularly vaginal microbiota.